Abstract:Background and Objectives: Pneumothorax implies the presence of air in the pleural space between the visceral and parietal pleura. The aim of this study was to investigate the incidence, clinical characteristics, risk factors, therapy and perinatal outcome in neonates with pneumothorax in a tertiary care center. Materials and Methods: A retrospective study based on a five-year data sample of neonates with pneumothorax was conducted in a Maternity Hospital with a tertiary NICU from 2015 to 2020. We included all… Show more
“…Although the risk of developing NP is high in premature infants who need resuscitation or who are exposed to IMV due to underlying respiratory problems, the incidence of primary NP in premature infants is also high. 9 , 16 In newborn infants, prematurity and RDS are the most common possible risk factors for NP. 5 According to the study conducted by Joshi et al, 7 50.1% of their study population consisted of preterm infants.…”
Section: Discussionmentioning
confidence: 99%
“… 5 - 7 On the other hand, secondary pneumothorax is defined as the pneumothorax that occurs due to traumatic injury to the pleura or risk factors such as meconium aspiration syndrome (MAS), respiratory distress syndrome (RDS), congenital pneumonia, transient tachypnea of the newborn (TTN), surfactant treatment, endotracheal suctioning, pulmonary hypoplasia, or congenital lung malformations, and the use of positive pressure ventilation (PPV) during resuscitation. 7 - 9 Respiratory distress syndrome was found to be the most common possible underlying lung disease of NP for preterm infants and TTN for term infants. 3 …”
Section: Introductionmentioning
confidence: 99%
“…There are mainly 3 options for the management of NP: (1) conservative treatment by giving only oxygen; (2) drainage with needle aspiration (NA) by temporary insertion of a needle into the pleural space; or (3) definitive drainage of the air by insertion of a chest drainage catheter (intercostal) into the pleural space. 9 , 10 The oxygen therapy is affected by nitrogen washout. Nitrogen flushing is thought to help resolve pneumothorax by increasing the nitrogen absorption gradient from the extrapulmonary space.…”
Section: Introductionmentioning
confidence: 99%
“…Although there are numerous studies in the literature on NP risk factors, especially in extremely preterm and term infants, studies comparing NP treatment strategies between preterm and term infants are very limited. 9 , 10 , 13 …”
Objective:
The study aimed to compare the risk factors, treatment strategies, and early outcomes of symptomatic neonatal pneumothorax (NP) between preterm and term newborns.
Materials and Methods:
This retrospective cross-sectional study was conducted in a neonatal intensive care unit between 2015 and 2022, consisting of hospitalized neonates with symptomatic NP. The cases were divided into three groups according to their gestational ages: <34
0/7
(group 1), 34
0/7
-36
6/7
(group 2), and ≥37
0/7
weeks (group 3). Risk factors, treatment strategies, and mortality rates of the study groups were compared using Kruskal–Wallis analysis.
Results:
Fifty-nine infants with a diagnosis of symptomatic NP were included in the study. The number of participants was as follows: 25 (42.3%) in group 1, 18 (30.5%) in group 2, and 16 (27.1%) in group 3. The need of delivery room (DR) resuscitation was significantly higher in group 1 (40%,
P
= .003). The surfactant administration rate was significantly higher in group 1 when compared to group 2 and group 3 (68% vs. 22% and 19%, respectively),
P
< .001. Similarly, the invasive mechanical ventilation percentage was significantly higher in group 1 than group 2 and group 3,
P
= .014. However, compared to group 3 (63%), the percentage of chest drain insertion (CDI) need was significantly higher in group 1 (96%) and group 2 (89%) (
P
= .014).
Conclusion:
Exposure to DR resuscitation and the need for surfactant are the most common risk factors for NP in preterm infants. Although oxygen and/or needle aspiration treatments are less invasive in symptomatic NP, the improvement rate without CDI is very low in preterm infants born before 34 weeks of gestational age.
“…Although the risk of developing NP is high in premature infants who need resuscitation or who are exposed to IMV due to underlying respiratory problems, the incidence of primary NP in premature infants is also high. 9 , 16 In newborn infants, prematurity and RDS are the most common possible risk factors for NP. 5 According to the study conducted by Joshi et al, 7 50.1% of their study population consisted of preterm infants.…”
Section: Discussionmentioning
confidence: 99%
“… 5 - 7 On the other hand, secondary pneumothorax is defined as the pneumothorax that occurs due to traumatic injury to the pleura or risk factors such as meconium aspiration syndrome (MAS), respiratory distress syndrome (RDS), congenital pneumonia, transient tachypnea of the newborn (TTN), surfactant treatment, endotracheal suctioning, pulmonary hypoplasia, or congenital lung malformations, and the use of positive pressure ventilation (PPV) during resuscitation. 7 - 9 Respiratory distress syndrome was found to be the most common possible underlying lung disease of NP for preterm infants and TTN for term infants. 3 …”
Section: Introductionmentioning
confidence: 99%
“…There are mainly 3 options for the management of NP: (1) conservative treatment by giving only oxygen; (2) drainage with needle aspiration (NA) by temporary insertion of a needle into the pleural space; or (3) definitive drainage of the air by insertion of a chest drainage catheter (intercostal) into the pleural space. 9 , 10 The oxygen therapy is affected by nitrogen washout. Nitrogen flushing is thought to help resolve pneumothorax by increasing the nitrogen absorption gradient from the extrapulmonary space.…”
Section: Introductionmentioning
confidence: 99%
“…Although there are numerous studies in the literature on NP risk factors, especially in extremely preterm and term infants, studies comparing NP treatment strategies between preterm and term infants are very limited. 9 , 10 , 13 …”
Objective:
The study aimed to compare the risk factors, treatment strategies, and early outcomes of symptomatic neonatal pneumothorax (NP) between preterm and term newborns.
Materials and Methods:
This retrospective cross-sectional study was conducted in a neonatal intensive care unit between 2015 and 2022, consisting of hospitalized neonates with symptomatic NP. The cases were divided into three groups according to their gestational ages: <34
0/7
(group 1), 34
0/7
-36
6/7
(group 2), and ≥37
0/7
weeks (group 3). Risk factors, treatment strategies, and mortality rates of the study groups were compared using Kruskal–Wallis analysis.
Results:
Fifty-nine infants with a diagnosis of symptomatic NP were included in the study. The number of participants was as follows: 25 (42.3%) in group 1, 18 (30.5%) in group 2, and 16 (27.1%) in group 3. The need of delivery room (DR) resuscitation was significantly higher in group 1 (40%,
P
= .003). The surfactant administration rate was significantly higher in group 1 when compared to group 2 and group 3 (68% vs. 22% and 19%, respectively),
P
< .001. Similarly, the invasive mechanical ventilation percentage was significantly higher in group 1 than group 2 and group 3,
P
= .014. However, compared to group 3 (63%), the percentage of chest drain insertion (CDI) need was significantly higher in group 1 (96%) and group 2 (89%) (
P
= .014).
Conclusion:
Exposure to DR resuscitation and the need for surfactant are the most common risk factors for NP in preterm infants. Although oxygen and/or needle aspiration treatments are less invasive in symptomatic NP, the improvement rate without CDI is very low in preterm infants born before 34 weeks of gestational age.
“…Male gender and cesarian delivery were identified as risk factors for pneumothorax development in most studies, which was confirmed in our study. 3,5,[27][28][29][30][31][32][33][34] Studies report that 51 to 77% of pneumothorax involve the right lung 3,5,31,32,34 and 11 to 24% are bilateral. 5,[30][31][32][33] Consistent with these studies, 65% of our patients had a right pneumothorax, and 25% had a bilateral pneumothorax.…”
This study aims to evaluate risk factors, respiratory support procedures, and characteristics of pneumothorax in late preterm and term newborns diagnosed with pneumothorax within the first 48 hours of life. The study included late preterm and term newborns diagnosed with pneumothorax within the first 48 hours of life. The neonates diagnosed with pneumothorax within the first 24 hours of life (Group 1) and those diagnosed between 24 and 48 hours (Group 2) were analyzed in terms of risk factors, respiratory support procedures, and characteristics of pneumothorax. Twenty newborns, 11 in Group 1 and 9 in Group 2, with a mean gestational age of 37.9 ± 1.2 weeks and birth weight of 3,133 ± 464 g, were included the study. The resuscitation rate in the delivery room was insignificantly higher in Group 1. There was no significant difference between the two groups in terms of respiratory support methods (mechanical ventilation [MV], noninvasive ventilation, oxygen) on admission and at the time of diagnosis. The rate of receiving MV during treatment was significantly higher in Group 2 (p = 0.014). Although duration of MV and chest drainage were significantly shorter in Group 1 (p = 0.026 and p = 0.026, respectively), when we considered only survivors (all three deceased newborns died within the first day of life), these durations were still shorter; however, the difference was no longer significant. Pneumothorax should be suspected in late preterm and term newborns with respiratory distress within the first 2 days of life, especially in the presence of risk factors.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.